CTNM - Bathi sadurunge bunga, pajak, lan amortisasi Contineum Therapeutics Inc

Contineum Therapeutics, Inc. (CTNM) focuses on developing small molecules for CNS therapies, investing in scientific potential. However, the lack of sales and reliance on grants create significant risks. The EBITDA breakdown clearly confirms the financial condition, where 0.00 reflects the latest value of the metric. Meanwhile, the company strictly adheres to environmental regulations regarding the disposal of laboratory waste.

CTNM Contineum Corp: Bathi sadurunge mbayar bunga, pajak, lan amortisasi ing interval 23.11.2025 - 15.11.2026

Ringkesan rincian data analitis Contineum Pharma (CTNM)

- rega saham lan prakiraan rega para ahli:

Kurs saham Contineum Therapeutics, Inc.|CTNM - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Nilai pasar Contineum Pharma|CTNM - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham Contineum Therapeutics|CTNM - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku contineum-tx.com|CTNM - Aset Agregat Perusahaan

- indikator total utang lan likuiditas perusahaan:

Utang marang Modal Contineum Therapeutics, Inc.|CTNM - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Contineum Corp|CTNM - Utang perusahaan|Utang-utang marang nilai buku Contineum Therapeutics, Inc.|CTNM - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Contineum Therapeutics|Likuiditas darurat contineum-tx.com

- data bathi bisnis lan rasio investasi:

CTNM - Bathi resik|Bathi mangsa ngarep Contineum Therapeutics, Inc.|CTNM - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Contineum Therapeutics Inc|CTNM - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Contineum Pharma|CTNM - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Contineum Therapeutics|CTNM - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan contineum-tx.com|CTNM - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Contineum Therapeutics, Inc.

- data dodolan lan asil:

CTNM - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan Contineum Therapeutics|CTNM - Kapitalisasi marang pendapatan|Multiplikator Forward P/S Contineum Therapeutics Inc|CTNM - Wutah dodolan YoY sajrone rolas wulan kepungkur

Analisis kabeh metrik perusahaan:Contineum Therapeutics, Inc.

Produk asil prodhuksi Contineum Therapeutics Inc

This metric reflects net cash flow from operating activities, excluding the impact of depreciation and taxes to assess the business's actual ability to generate cash. Analyzing the absolute operating profit of Contineum Therapeutics, Inc. (CTNM) in monetary terms allows for the timely detection of liquidity shortages, which is critical for Contineum Therapeutics, Inc. (CTNM) amid fierce competition with biotech behemoths and the high risks associated with clinical trials.

Karo sapa Contineum Therapeutics, Inc. saingan